Larson Financial Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Larson Financial Group's RVMD Position: Q3 2026 in Review
Larson Financial Group increased its Revolution Medicines (RVMD) stake by 35% in Q3 2026, buying an estimated $14.3K and bringing the position to 280 shares worth $57.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1545.
Larson Financial Group first reported a position in RVMD in Q3 2024 and has held it in 7 quarters since. 753 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Larson Financial Group held 280 shares of Revolution Medicines worth $57.5K as of Q3 2026.
- Larson Financial Group bought 72 Revolution Medicines shares in Q3 2026, an estimated $14.3K.
- Revolution Medicines made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1545 holding.
- Larson Financial Group first reported a position in Revolution Medicines in Q3 2024 and has held it in 7 quarters since.
- 753 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.